Abstract
Benefits of this report
- Up-to-date one-stop information on transdermal drug delivery
- Description of 114 companies involved and 100 collaborations in this area
- Market analysis 2008-2018/
- Market values in major regions
- Strategies for developing markets for transdermal drug delivery
- A selected bibliography of 170 publications
- Text is supplemented by 16 tables and 10 figures
Who should read this report?
- Biotechnology companies developing transdermal technologies
- Drug delivery companies
- Pharmaceutical companies interested in transdermal drug delivery
- Pharmaceutical research institutes
Summary
This report deals with transdermal drug delivery - an approach used to deliver
drugs through the skin for therapeutic use as an alternative to
oral,intravascular, subcutaneous and transmucosal routes. Various transdermal
drug delivery technologies are described including the use of suitable
formulations, carriers and penetration enhancers. The most commonly used
transdermal system is the skin patch using various types of technologies.
Nanoparticles as well as the use of physical agents to facilitate
transcutaneous drug delivery is described. Microneedle and needleless
technologies are also described. Transdermal technologies may be applied for
several categories of pharmaceuticals used for the treatment of disorders of
the skin or for systemic effect to treat diseases of other organs. Several
transdermal products and applications include hormone replacement therapy,
management of pain, angina pectoris, smoking cessation and neurological
disorders such as Parkinson' s disease. The market for transdermal drug
delivery is analyzed according to technologies and therapeutic areas from 2008
to 2018.This market is analyzed according to geographical regions as well.
View Cart
